GENEVA, July 6 -- GUANGZHOU NATIONAL LABORATORY filed a patent application (CN2025/118306) for “USE OF FARNESOL X RECEPTOR AGONIST IN PREVENTING AND/OR TREATING FIBROSIS”. With publication no. WO/2026/137950, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 45/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....